X-101407750-A-G
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000169.3(GLA):c.154T>C(p.Cys52Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C52S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000169.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
The C52R pathogenic variant in the GLA gene has been reported in at least one patient diagnosed with Fabry disease (Blanch et al., 1996). In addition, variants in the same codon (C52Y, C52W) have been reported in the literature (Parini et al., 2008; Lukas et al., 2013) and classified as a pathogenic or likely pathogenic based on review of the data in the context of the 2015 ACMG Standards and guidelines for the interpretation of sequence variants (Richards et al., 2015). Other missense variants in the same codon (C52G, C52S) have also been reported in the Human Gene Mutation Database in association with Fabry disease (Stenson et al., 2014). The C52R variant results in a non-conservative amino acid substitution at a position that is conserved across species and is involved in a disulfide bond with another residue in the GLA gene. In silico analysis predicts this variant is probably damaging to the protein structure/function. Finally, the C52R pathogenic variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. -
Fabry disease Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at